Safety Profile in Hyaluronic Acid‐Based Vocal Fold Injection Augmentation
The Laryngoscope · 2026-08 · 136 (8) · 3541-3547
DOI: 10.1002/lary.70513 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 23.03.2026. Verfasst von Noah Thornton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Hyaluronic Acid, Vocal Cords, Vocal Cord Paralysis. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
The study's objective is to assess the safety profile and complication rates of hyaluronic acid‐based vocal fold injection augmentation (VFIA), specifically evaluating inflammatory reactions, injection volume, and COVID‐19 vaccination status.
Methods
A retrospective cohort study was conducted of 299 VFIA procedures performed using Restylane‐L at a single academic institution. Medical charts were reviewed to collect patient demographics, injection details (approach, location, and volume), videolaryngostroboscopy exams, and post‐injection outcomes, including complication rates and nature of inflammatory reactions.
Results
The overall complication rate was 4.0% (12/299), with inflammatory complications comprising 2.34% (7/299) of cases. Inflammatory symptoms developed a mean of 4.3 days after injection (median: 3 days; range: 12 h–10 days) and resolved in all cases with corticosteroid therapy. A statistically significant difference in injection volume was noted among groups ( p = 0.037), although post hoc comparisons did not demonstrate significance. COVID‐19 vaccination status was not associated with complication rates ( p = 0.84).
Conclusions
VFIA using HA‐based material demonstrates a low rate of complications, and all inflammatory reactions resolved with medical management. Injection volume may play a role in complication risk, but further multi‐site studies are needed. No association between COVID‐19 vaccination and adverse outcomes was identified. Level of Evidence 3
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
ORCID-Profile: James J Daniero
Zitieren
APA
Thornton, N., Stepp, R., Nguyenkhoa, V., Leder Macek, A., & Daniero, J. J. (2026). Safety Profile in Hyaluronic Acid‐Based Vocal Fold Injection Augmentation. The Laryngoscope, 136(8), 3541-3547. https://doi.org/10.1002/lary.70513
Vancouver
Thornton N, Stepp R, Nguyenkhoa V, Leder Macek A, Daniero JJ. Safety Profile in Hyaluronic Acid‐Based Vocal Fold Injection Augmentation. The Laryngoscope. 2026;136(8):3541-3547. doi:10.1002/lary.70513
BibTeX
@article{Thornton2026,
author = {Thornton, Noah and Stepp, Ryan and Nguyenkhoa, Vincent and Leder Macek, Aleeza and Daniero, James J},
title = {Safety Profile in Hyaluronic Acid‐Based Vocal Fold Injection Augmentation},
journal = {The Laryngoscope},
year = {2026},
volume = {136},
number = {8},
pages = {3541--3547},
doi = {10.1002/lary.70513}
}
EUVIMED